Article: P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase

€3.03

SKU: product-article-15302 Category: General

Description
Reviews (0)

Description

P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase

Reviews

There are no reviews yet.

Be the first to review “Article: P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase”

You must be logged in to post a review.

Top

Article: P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase

Description

Reviews

Related products

Article: Calendar of events

Article: Highlights in gynaecological cancers

Article: Highlights in urologic cancer

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer